Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia 53Lymphoma 51Melanoma 44Breast Neoplasms 37Lymphoma, Follicular 36Leukemia, Myeloid, Acute 33Leukemia, Lymphocytic, Chronic, B-Cell 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Lymphoma, Non-Hodgkin 29Neuroblastoma 28Multiple Myeloma 28Lymphoma, Large B-Cell, Diffuse 25Prostatic Neoplasms 24Lymphoma, Mantle-Cell 23Myelodysplastic Syndromes 22Lymphoma, Large-Cell, Immunoblastic 20Neoplasms, Plasma Cell 19Leukemia, Myeloid, Chronic-Phase 19Lung Neoplasms 18Hodgkin Disease 18Carcinoma, Non-Small-Cell Lung 18Burkitt Lymphoma 18Ovarian Neoplasms 17Lymphoma, B-Cell, Marginal Zone 17Neoplasm Metastasis 16Glioblastoma 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15Congenital Abnormalities 15Leukemia, Myeloid, Accelerated Phase 14Colorectal Neoplasms 13

Interventions

abemaciclib 2Radiotherapy 2sargramostim 1ribociclib 1palbociclib 1niraparib 1exemestane 1Mastectomy, Segmental 1Mastectomy 1Letrozole 1Growth and Development 1Fulvestrant 1Everolimus 1Cyclophosphamide 1Continuous Positive Airway Pressure 1Colony-Stimulating Factors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unilateral Breast Neoplasms × sargramostim × Clear all
NCT03012100 2023-01-13

Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer

Academic and Community Cancer Research United

Phase 2 Active not recruiting
280 enrolled
Breast

Unilateral Breast Neoplasms, Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡